Tokyo.- A university in Japan today announced that they had made the first stem cell transplant from induced pluripotency (IPS) to treat malignancy Parkinson's.
Transplantation, the first of its kind in the world for Parkinson's care, was conducted last month by Kyoto University Hospital, the education center reported today.
Recipients are patients around 50 years old, whose identity is not given, who will undergo periodic examinations for two years to avoid rejection.
"We trepanned the left side of the head (patient) and transplanted 2.4 million cells," surgeon Takayuki Kikuchi from Kyoto University told reporters, according to the local Kyodo news agency.
The cells used are made using iPS stem cells from donors who have several types of immunity that make them less likely to resist transplants.
The Parkinson's disease, which implies chronic degeneration of neurons, there is still no cure. Only in Japan It is estimated that there are 160,000 people with progressive neurological disorders.
On March 29, 2017, scientists from Kobe General Medical Center, in western Japan, announced the first surgical transplant in humans with iPS cells in the patient's retina.
Patients, affected by macular retinal degeneration – a difficult ocular disorder that can cause blindness – receive injections of solutions with retinal cells developed from other iPS from donors.